Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Influenza and Other Respiratory Viruses|January 22, 2021
Absence of association between 2019-20 influenza vaccination and COVID-19: Results of the European I-MOVE-COVID-19 primary care project, March-August 2020Esther Kissling, Mariëtte Hooiveld, Mia Brytting, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 5, 2019
Low 2018/19 vaccine effectiveness against influenza A(H3N2) among 15-64-year-olds in Europe: exploration by birth cohortEsther Kissling, Francisco Pozo, Silke Buda, et al.
Viruses|May 28, 2022
Seroprevalence of SARS-CoV-2 IgG Antibodies and Factors Associated with SARS-CoV-2 IgG Neutralizing Activity among Primary Health Care Workers 6 Months after Vaccination Rollout in FranceDorine Decarreaux, Marie Pouquet, Cecile Souty, et al.
Influenza and Other Respiratory Viruses|November 11, 2017
2015/16 I-MOVE/I-MOVE+ multicentre case-control study in Europe: Moderate vaccine effectiveness estimates against influenza A(H1N1)pdm09 and low estimates against lineage-mismatched influenza B among childrenEsther Kissling, Marta Valenciano, Francisco Pozo, et al.
Influenza and Other Respiratory Viruses|April 17, 2018
Exploring the effect of previous inactivated influenza vaccination on seasonal influenza vaccine effectiveness against medically attended influenza: Results of the European I-MOVE multicentre test-negative case-control study, 2011/2012-2016/2017Marta Valenciano, Esther Kissling, Amparo Larrauri, et al.
Vaccine: X|October 30, 2019
Effectiveness of influenza vaccine against influenza A in Europe in seasons of different A(H1N1)pdm09 and the same A(H3N2) vaccine components (2016-17 and 2017-18)Esther Kissling, Francisco Pozo, Silke Buda, et al.
Influenza and Other Respiratory Viruses|January 26, 2023
Influenza vaccine effectiveness against influenza A subtypes in Europe: Results from the 2021-2022 I-MOVE primary care multicentre studyEsther Kissling, Francisco Pozo, Iván Martínez-Baz, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|July 23, 2021
Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021Esther Kissling, Mariette Hooiveld, Virginia Sandonis Martín, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 27, 2022
Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe: multicentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021Esther Kissling, Mariëtte Hooiveld, Iván Martínez-Baz, et al.
Pageof 3